CAS: 2083618-79-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-cyclopenta[D][1,2,4]triazolo[1,5 -a]pyrimidine-2-carboxamide REF: 3D-IID61879CAS: 2083618-79-3 | Min. 95% | A consultar | Vie 03 Ene 25 |
 | PDZ1i REF: TM-T63797CAS: 2083618-79-3 | - - - | 1.386,00 €~2.279,00 € | Vie 10 Ene 25 |
N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-cyclopenta[D][1,2,4]triazolo[1,5 -a]pyrimidine-2-carboxamide
CAS:2083618-79-3
N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-[1] -cyclopenta[D][1,2,4]triazolo[1,5]pyrimidine-2 -carboxamide is a peptidomimetic inhibitor of the protein kinase PIM. It has been …
Fórmula:
C28H26N8O4
Pureza:
Min. 95%
Peso molecular:
538.6 g/mol
Ref: 3D-IID61879
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 3 de Enero de 2025
PDZ1i
CAS:2083618-79-3
PDZ1i: potent MDA-9/Syntenin inhibitor; crosses blood-brain barrier; targets GBM, FAK, EGFRvIII; lowers MMP secretion.
Fórmula:
C28H26N8O4
Forma y color:
Solid
Peso molecular:
538.56
Ref: TM-T63797
| 25mg | 1.386,00 € | ||
| 50mg | 1.805,00 € | ||
| 100mg | 2.279,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Enero de 2025
